(Q53304500)

13 May 2018

title

Prolactin receptor attenuation induces zinc pool redistribution through ZnT2 and decreases invasion in MDA-MB-453 breast cancer cells. (English)

1 reference

13 May 2018

author name string

Zeynep Bostanci

1

1 reference

13 May 2018

Samina Alam

2

1 reference

13 May 2018

David I Soybel

3

1 reference

13 May 2018

Shannon L Kelleher

4

1 reference

13 May 2018

language of work or name

English

0 references

publication date

11 December 2013

1 reference

13 May 2018

Experimental Cell Research

published in

1 reference

13 May 2018

volume

321

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

190-200

1 reference

13 May 2018

A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Ligand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Short form 1b human prolactin receptor down-regulates expression of the long form

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Dopamine antagonists and the development of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Expression of prolactin and its receptor in human breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Zip3 plays a major role in zinc uptake into mammary epithelial cells and is regulated by prolactin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Zinc transporter-2 (ZnT2) variants are localized to distinct subcellular compartments and functionally transport zinc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

A histidine-rich motif mediates mitochondrial localization of ZnT2 to modulate mitochondrial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

X-ray fluorescence microscopy reveals accumulation and secretion of discrete intracellular zinc pools in the lactating mouse mammary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Regulation of metallothionein gene expression by oxidative stress and metal ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Inhibition of Invasion and Angiogenesis by Zinc-Chelating Agent Disulfiram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Zinc transporter 2 (SLC30A2) can suppress the vesicular zinc defect of adaptor protein 3-depleted fibroblasts by promoting zinc accumulation in lysosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Identification and characterization of microRNAs expressed in human breast cancer T-47D cells in response to prolactin treatment by Solexa deep-sequencing technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Divalent metal ions in plant mitochondria and their role in interactions with proteins and oxidative stress-induced damage to respiratory function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Role of the conserved histidine and aspartic acid residues in activity and stabilization of human gelatinase B: an example of matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Zinc-binding groups modulate selective inhibition of MMPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Apolactoferrin inhibits the catalytic domain of matrix metalloproteinase-2 by zinc chelation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Cytotoxicity of zinc in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Zinc(II) ion mediates tamoxifen-induced autophagy and cell death in MCF-7 breast cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Involvement of reactive oxygen species (ROS) in the induction of genetic instability by radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Re-evaluation of the prolactin receptor expression in human breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Zinc transporters in the rat mammary gland respond to marginal zinc and vitamin A intakes during lactation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

Tracing of labile zinc in live fish hepatocytes using FluoZin-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

ZnT2-overexpression represses the cytotoxic effects of zinc hyper-accumulation in malignant metallothionein-null T47D breast tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.12.005

10.1016/J.YEXCR.2013.12.005

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018